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Background
In Steven Johnson’s syndrome (SJS) and Toxic epidermal
necrolysis (TEN), Chung et al. demonstrated that
granulysin is the key cytotoxic molecule. But the specifi-
city of granulysin in SJS-TEN is actually discussed. We
studied the granulysin expression of 6 types of cutaneous
adverse drug reaction (CADR) with a proven diagnosis
(maculopapular exanthema (MPE), Drug Reaction with
Eosinophilia and Systemic Symptoms (DRESS), fixed drug
eruption (FDE), SJS, TEN, acute generalized exanthema-
tous pustulosis (AGEP)).
Method
This retrospective histological analysis consisting of second
reading of anonymous slides. It was about skin biopsies (B)
from patients during a proven CADR (chronological inves-
tigation, single attributable drug or/and skin tests realised).
We used an immunohistochemical (IC) technique (clone
RF10, MBL DA86-3) to study the granulysin expression.
The distribution pattern of granulysin was analysed quali-
tatively (localisation) and graded semiquantitatively as
absent, mild, moderate or severe (0 to 3).
Results
102 biopsies were analysed resulting from 98 patients. For
the 4 additional biopsies, twice were realised during the
same episode. The discharge diagnosis was MPE in 31
patients (34 B), DRESS in 24 (25 B), SJS in 14, TEN in 7,
FDE in 10 (11 B) and AGEP in 12. Among these 102 pre-
levements, the IC technique didn’t work in 3 cases.
The skin tests were done in 77%, for the remaining 23% a
single drug was attributable. We observed that the granu-
lysin was expressed in these 6 CADR with different
intensities and localisations. There was no statistically dif-
ference between SJS and NET. In MPE the granulysin is
expressed in the epidermis but only mildly in 41%. In
DRESS cases, the expression is more intense and frequent
(76%) (p=0.0002). In the dermis, in MPE and DRESS there
is the same number of positively slides (88%). In MPE the
expression is mild and principaly superficial, whereas in
DRESS it is mostly moderate or intense and often deeper
with statistically significative differences. Between DRESS
and SJS+NET there are few statistically differences, except
in the superficial dermis the expression is more intense in
DRESS cases (p=0.0071).
Conclusion
This study allowed to determine that the granulysin
expression is not specific to SJS and TEN and bring to the
fore that it is also strongly expressed in the DRESS. The
IC expression of the granulysin could help to distinguish
MPE to the DRESS particularly in the early phase.
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